ENANTA PHARMACEUTICALS, INC Cash and Cash Equivalents
ENANTA PHARMACEUTICALS, INC (ENTA) had Cash and Cash Equivalents of $33.42 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $33.42M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $34.93M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $37.44M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $32.30M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $33.42M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $34.93M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $37.44M 10-Q · filed 2026-02-11 |
| 2025-09-30 | $32.30M 10-Q · filed 2026-08-12 |
| 2025-06-30 | $44.81M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $60.21M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $84.35M 10-Q · filed 2025-02-12 |
| 2024-09-30 | $37.23M 10-K · filed 2025-11-19 |
| 2024-06-30 | $35.77M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $63.54M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $39.93M 10-Q · filed 2024-02-08 |
| 2023-09-30 | $85.39M 10-K · filed 2024-11-27 |
| 2023-06-30 | $95.18M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $73.18M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $42.22M 10-Q · filed 2023-02-08 |
| 2022-09-30 | $43.99M 10-K · filed 2023-11-22 |
| 2022-06-30 | $28.37M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $40.99M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $99.07M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $57.21M 10-K · filed 2022-11-23 |
| 2021-06-30 | $4.60M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $77.13M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $55.09M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $87.13M 10-K · filed 2021-11-24 |
| 2020-06-30 | $99.86M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $74.34M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $27.56M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $51.23M 10-K · filed 2020-11-25 |
| 2019-06-30 | $94.21M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $106.03M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $74.36M 10-Q · filed 2019-02-08 |
| 2018-09-30 | $63.90M 10-K · filed 2019-11-27 |
| 2018-06-30 | $42.48M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $66.93M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $68.05M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $65.67M 10-K · filed 2018-11-29 |
| 2017-06-30 | $22.26M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $19.21M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $20.62M 10-Q · filed 2018-02-09 |
| 2016-09-30 | $16.58M 10-K · filed 2018-11-29 |
| 2016-06-30 | $24.79M 10-Q · filed 2017-08-09 |
| 2016-03-31 | $56.36M 10-Q · filed 2017-05-10 |
| 2015-12-31 | $46.23M 10-Q · filed 2017-02-09 |
| 2015-09-30 | $21.73M 10-K · filed 2018-11-29 |
| 2015-06-30 | $19.84M 10-Q · filed 2016-08-09 |
| 2015-03-31 | $25.75M 10-Q · filed 2016-05-10 |
| 2014-12-31 | $34.13M 10-Q · filed 2016-02-09 |
| 2014-09-30 | $30.70M 10-K · filed 2017-12-11 |
| 2014-06-30 | $26.37M 10-Q · filed 2015-08-10 |
| 2014-03-31 | $18.10M 10-Q · filed 2015-05-08 |
| 2013-12-31 | $4.43M 10-Q · filed 2015-02-06 |
| 2013-09-30 | $8.86M 10-K · filed 2016-12-09 |
| 2013-06-30 | $18.88M 10-Q · filed 2014-08-12 |
| 2013-03-31 | $74.46M 10-Q · filed 2014-05-12 |
| 2012-12-31 | $20.73M 10-Q · filed 2014-02-13 |
| 2012-09-30 | $10.51M 10-K · filed 2015-12-11 |
| 2012-06-30 | $3.96M 10-Q · filed 2013-08-12 |
| 2012-03-31 | $20.70M 10-Q · filed 2013-05-15 |
| 2011-09-30 | $6.84M 10-K · filed 2014-12-11 |
| 2010-09-30 | $466.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |